Patient-reported barriers to osteoporosis therapy

Reasons for not initiating osteoporosis therapy among a managed care population

(2015) Ankita Modi et al.   Patient Preference and Adherence

Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiaries

(2014) Huifeng Yun et al.   BMC MUSCULOSKELETAL DISORDERS

Estimating prevalence of osteoporosis: examples from industrialized countries

(2014) S. W. Wade et al.   Archives of Osteoporosis

Substantial under-treatment among women diagnosed with osteoporosis in a US managed-care population: a retrospective analysis

(2013) Ethel S. Siris et al.   CURRENT MEDICAL RESEARCH AND OPINION

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis

(2013) Nelson Watts et al.   Endocrine Practice

Factors associated with treatment of women with osteoporosis or osteopenia from a national survey

(2012) Eric S Meadows et al.   BMC Womens Health

Gastrointestinal side effects in postmenopausal women using osteoporosis therapy: 1-year findings in the POSSIBLE US study

(2010) Claudine Woo et al.   CURRENT MEDICAL RESEARCH AND OPINION

Persistence and switching patterns among women with varied osteoporosis medication histories: 12-month results from POSSIBLE US™

(2010) A. N. A. Tosteson et al.   OSTEOPOROSIS INTERNATIONAL

Predictors of oral bisphosphonate prescriptions in post-menopausal women with osteoporosis in a real-world setting in the USA

(2009) C. Asche et al.   OSTEOPOROSIS INTERNATIONAL

Patient Decision to Initiate Therapy for Osteoporosis: The Influence of Knowledge and Beliefs

(2008) Robert A. Yood et al.   JOURNAL OF GENERAL INTERNAL MEDICINE